IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
KRM Ayurveda Ltd.
Issue Open Date 21-Jan-26  
Issue Closing Date 23-Jan-26  
Application Money 100  
Allotment Money  
Price Band 128 - 135  
Minimium Application No. 2000  
Issue Size (Shares) 5740000  
Market Lot 1.00  
Objective
1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities;2. Purchase of CRM Software and Hardware Infrastructure;3. Human Resources;4. Repayment/Prepayment of loan;5. To meet out the Working Capital requirements of the Company and6. To meet out the General Corporate Purposes;
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
Our Company, established in 2019, is operating a network of hospitals and clinics across multiple cities in India aswell as marked its presence in abroad through telemedicines consulting and sales. We integrate authentic Ayurvedicwisdom with modern practices t
more...
Promoter's Holding
Total Share Capital   14303500  
Offered to Public   5740000  
Promoter's Holding (Pre-Issue)   92.15  
Promoter's Holding (Post-Issue)    
Address
A-16
G T Karnal Road
Industrial Area
North West
Delhi ,
Delhi ,
110033
Phone: 9289101700
Email: compliance@krmayurveda.com
Website: www.krmayurvedaindia.com
Registrar
Skyline Financial Services Pvt Ltd
123
Vinoba Puri
Lajpat Nagar - II

New Delhi
Listed at
NSE
Lead Manager
Nexgen Financial Solution Pvt Ltd.
Promoters
Puneet Dhawan
Tanya Dhawan
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.